Value is all about what a company is worth versus what price it is
available for. If you went into a grocery store and all the bananas were on sale
at half price, they could be considered
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
It is not possible to calculate the future cash flow value for
Allegra Orthopaedics. This is due to cash flow or dividend data being
unavailable. The share price is
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for
it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing
when they are out of season, or how much your home is worth.
The amount the stock market is willing to pay for
is considered below, and whether this is a fair price.
Price based on past earnings
Allegra Orthopaedics's earnings available for a low price, and how does
this compare to other companies in the same industry?
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Allegra Orthopaedics has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.
Show me the analysis anyway
The future performance of a company is measured in the same way as past
performance, by looking at estimated
and how much profit it is expected to make.
Future estimates come from
professional analysts. Just like forecasting the weather, they don’t always get
Expected Medical Equipment industry annual growth in earnings.
Earnings growth vs Low Risk Savings
expected to grow at an
Unable to compare Allegra Orthopaedics's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
Unable to compare Allegra Orthopaedics's earnings growth to the Australia market average as no estimate data is available.
Unable to compare Allegra Orthopaedics's revenue growth to the Australia market average as no estimate data is available.
Unable to determine if Allegra Orthopaedics is high growth as no earnings estimate data is available.
Unable to determine if Allegra Orthopaedics is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can
be gauged below. We look back 3 years and see if they were any good at
predicting what actually occurred. We also show the highest and lowest estimates
looking forward to see if there is a wide range.
Allegra Orthopaedics's performance over the past 5 years by checking for:
Has earnings increased in past 5 years? (1 check)
Has the earnings growth in the last year exceeded that of the
industry? (1 check)
Is the recent earnings growth over the last year higher than the average annual growth over the
past 5 years? (1 check)
Is the Return on Equity (ROE) higher than 20%? (1 check)
Is the Return on Assets (ROA) above industry average? (1 check)
Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent
earnings report. Some checks require at least 3 or 5 years worth of data.
has a total score of
0/6, see the detailed checks below.
Note: We use GAAP Net Income excluding extraordinary items in all our calculations.
A company's financial position is much like your own financial position,
it includes everything you own
The boxes below represent the relative size of what makes up
Allegra Orthopaedics's finances.
The net worth of a company is the difference between its assets and liabilities.
Allegra Orthopaedics is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
Allegra Orthopaedics's cash and other short term assets cover its long term commitments.
This treemap shows a more detailed breakdown of
Allegra Orthopaedics's finances. If any of them are yellow this
indicates they may be out of proportion and red means they relate to one of the
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
High level of physical assets or inventory.
Allegra Orthopaedics has no debt, it does not need to be covered by short term assets.
Nearly all companies have debt. Debt in itself isn’t
however if the debt is too high, or the company can’t afford to pay the interest
on its debts this may have impacts in the future.
The graphic below shows equity (available funds) and debt, we ideally want to
see the red area (debt) decreasing.
If there is any debt we look at the companies capability to repay it, and
whether the level has increased over the past 5 years.
Management is one of the most important areas of a company. We look at
unreasonable CEO compensation, how long the team and board of directors have
been around for and insider trading.
TENURE AS CEO
Ms. Jenny Swain has been the Chief Executive Officer of Allegra Orthopaedics Limited since May 2, 2016. Ms. Swain served as Director Sales and Marketing of Allegra Orthopaedics Limited and served as its National Sales Manager. She has over 15 years experience in orthopaedic sales and support. Prior to moving into a sales function, she spent 12 years as a formally trained and qualified Registered Nurse with practical experience in local and overseas hospitals. This included 5 years in Los Angeles Century City Hospital as orthopaedic Unit Manager. She joined J&J in 1996 at NSW Orthopaedic Territory Manager and in February, 2000 joined Taylor Bryant now Lifehealthcare as Divisional Manager for Orthopaedic Division. She has worked on a national level with orthopaedic surgeons specialising in small and large joints and has strong relationships not only domestically but internationally.
Jenny's compensation has increased whilst company is loss making.
Jenny's remuneration is about average for companies of similar size in Australia.
Management Team Tenure
Average tenure of the
management team in years:
The tenure for the Allegra Orthopaedics management team is about average.
Chief Executive Officer
Commercial & Finance Manager
Board of Directors Tenure
Average tenure and age of the
board of directors in years:
The tenure for the Allegra Orthopaedics board of directors is about average.
Board of Directors
Sean St Mulhearn
Who owns this company?
Recent Insider Trading
No 3 month individual insider trading information.
Is Allegra Orthopaedics Limited's (ASX:AMT) CEO Paid At A Competitive Rate?
See our latest analysis for Allegra Orthopaedics How Does Jenny Swain's Compensation Compare With Similar Sized Companies? … According to our data, Allegra Orthopaedics Limited has a market capitalization of AU$7.9m, and pays its CEO total annual compensation worth AU$364k. … ASX:AMT CEO Compensation, June 12th 2019 Is Allegra Orthopaedics Limited Growing?
Is Allegra Orthopaedics's Share Price Gain Of 133% Well Earned?
One great example is Allegra Orthopaedics Limited (ASX:AMT) which saw its share price drive 133% higher over five years. … Given that Allegra Orthopaedics didn't make a profit in the last twelve months, we'll focus on revenue growth to form a quick view of its business development. … When a company doesn't yet make profits, we'd generally expect to see good revenue growth.
Are Allegra Orthopaedics Limited's (ASX:AMT) Interest Costs Too High?
The direct benefit for Allegra Orthopaedics Limited (ASX:AMT), which sports a zero-debt capital structure, to include debt in its capital structure is the reduced cost of capital. … Is financial flexibility worth the lower cost of capital. … There are well-known benefits of including debt in capital structure, primarily a lower cost of capital
I am going to take a deep dive into Allegra Orthopaedics Limited’s (ASX:AMT) most recent ownership structure, not a frequent subject of discussion among individual investors. … The impact of a company's ownership structure affects both its short- and long-term performance. … Therefore, it is beneficial for us to examine AMT's ownership structure in more detail.
Should You Sell Allegra Orthopaedics Limited (ASX:AMT) At This PE Ratio?
and want to better understand how you can grow your money by investing in Allegra Orthopaedics Limited (ASX:AMT). … Allegra Orthopaedics Limited (ASX:AMT) is currently trading at a trailing P/E of 87.4x, which is higher than the industry average of 49.2x. … While this makes AMT appear like a stock to avoid or sell if you own it, you might change your mind after I explain the assumptions behind the P/E ratio
What Investors Should Know About Allegra Orthopaedics Limited's (ASX:AMT) Financial Strength
Last year, AMT’s operating cash flow was 0.99x its current debt. … AMT has demonstrated its ability to generate sufficient levels of cash flow, while its debt hovers at a safe level. … AMT’s high cash coverage and low levels of debt indicate its ability to use its borrowings efficiently in order to produce a healthy cash flow.
Allegra Orthopaedics Limited designs, sells, and distributes surgical implants in Australia. It offers adult and adolescent clavicle fixation systems and pins; shoulder implants; hand fracture plates and ulna heads, compression screws, distal radius systems, and hand fracture systems; hip and heads, CSF cups, and evolution and resurfacing hip products; and knee replacement systems, knee distal first instruments, and screws, as well as femoral condyle, PF wave, and nanofracture technology products. The company also provides foot and ankle products, such as total ankle replacement systems, toe products, A-curve handles, screws, and staples; surgical screws, sawblades, and kirschner wires; and microfracture handles. In addition, it offers consulting services. The company was formerly known as Advanced Surgical Design & Manufacture Limited and changed its name to Allegra Orthopaedics Limited in November 2014. Allegra Orthopaedics Limited was founded in 1994 and is based in Lane Cove West, Australia.
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.